390 related articles for article (PubMed ID: 26799420)
1. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway.
Su X; Wang J; Chen W; Li Z; Fu X; Yang A
Oncotarget; 2016 Mar; 7(9):9939-50. PubMed ID: 26799420
[TBL] [Abstract][Full Text] [Related]
2. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of INSR/IGF1R by C-myc promotes TSCC tumorigenesis and metastasis through the NF-κB pathway.
Sun J; Lu Z; Deng Y; Wang W; He Q; Yan W; Wang A
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1873-1882. PubMed ID: 29518496
[TBL] [Abstract][Full Text] [Related]
4. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
Wang X; Guo H; Yao B; Helms J
Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
[TBL] [Abstract][Full Text] [Related]
5. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
6. Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma.
Wang Y; Lin Z; Sun L; Fan S; Huang Z; Zhang D; Yang Z; Li J; Chen W
Br J Cancer; 2014 Feb; 110(3):695-705. PubMed ID: 24346284
[TBL] [Abstract][Full Text] [Related]
7. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway.
Duan M; Du X; Ren G; Zhang Y; Zheng Y; Sun S; Zhang J
Mol Med Rep; 2018 Aug; 18(2):1651-1659. PubMed ID: 29845251
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
[TBL] [Abstract][Full Text] [Related]
12. AEG-1 activates Wnt/PCP signaling to promote metastasis in tongue squamous cell carcinoma.
Pan Y; Guo X; Yang Z; Chen S; Lei Y; Lin M; Wang L; Feng C; Ke Z
Oncotarget; 2016 Jan; 7(2):2093-104. PubMed ID: 26689985
[TBL] [Abstract][Full Text] [Related]
13. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma.
Jia LF; Wei SB; Gan YH; Guo Y; Gong K; Mitchelson K; Cheng J; Yu GY
Int J Cancer; 2014 Nov; 135(10):2282-93. PubMed ID: 24343426
[TBL] [Abstract][Full Text] [Related]
14. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
[TBL] [Abstract][Full Text] [Related]
16. High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma.
Chen S; Li H; Li X; Chen W; Zhang X; Yang Z; Chen Z; Chen J; Zhang Y; Shi D; Song M
Cancer Med; 2020 Jun; 9(12):4274-4289. PubMed ID: 32307911
[TBL] [Abstract][Full Text] [Related]
17. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma.
Zhang H; Chen W; Fu X; Su X; Yang A
Gene; 2018 May; 654():49-56. PubMed ID: 29462646
[TBL] [Abstract][Full Text] [Related]
18. Suppression of tongue squamous cell carcinoma growth by inhibition of Jagged1 in vitro and in vivo.
Zhang TH; Liu HC; Liang YJ; Liang LZ; Zheng GS; Huang HZ; Wu JN; Liao GQ
J Oral Pathol Med; 2013 Apr; 42(4):322-31. PubMed ID: 23157415
[TBL] [Abstract][Full Text] [Related]
19. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
[TBL] [Abstract][Full Text] [Related]
20. The downregulation of ANGPTL4 inhibits the migration and proliferation of tongue squamous cell carcinoma.
Huang Z; Xie J; Lin S; Li S; Huang Z; Wang Y; Ye J
Arch Oral Biol; 2016 Nov; 71():144-149. PubMed ID: 27505034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]